{"id":197672,"date":"2026-08-12T10:02:36","date_gmt":"2026-08-12T04:32:36","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=197672"},"modified":"2026-08-12T10:02:38","modified_gmt":"2026-08-12T04:32:38","slug":"hikal-vs-solara-active-pharma-sciences-comparison","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/hikal-vs-solara-active-pharma-sciences-comparison\/","title":{"rendered":"Hikal vs Solara Active Pharma Sciences: Share Price, Comparison and Key Differences"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Hikal MCap Rs 2,800 Cr, loss-making (EPS -2.74, ROE 3.03%). Solara Active Pharma Sciences MCap Rs 2,400 Cr, loss-making (EPS -0.34, ROE -0.12%). Both companies are currently loss-making.<\/em><\/p>\n<p>Hikal vs Solara Active Pharma Sciences is a comparison API and specialty chemical investors look up when evaluating two listed Indian companies in the pharma API and crop protection chemical segment. Hikal Limited, a Mumbai-based company, manufactures pharma APIs and crop protection chemicals (herbicides, fungicides) for the global market. Solara Active Pharma Sciences, a Chennai-based company, is an API manufacturer that emerged from Strides-Shasun&#8217;s merger and focuses on complex APIs for regulated markets. Both Hikal vs Solara Active Pharma Sciences are currently loss-making &#8211; investors should note this prominently before any investment decision.<\/p>\n<p>This Hikal vs Solara Active Pharma Sciences article covers reach and market position, key products, latest declared results and stock valuation. All data is sourced from Groww and public company filings.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/hikal-vs-solara-active-pharma-sciences-comparison\/#Reach_and_Market_Position\" title=\"Reach and Market Position\">Reach and Market Position<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/hikal-vs-solara-active-pharma-sciences-comparison\/#Key_Products_and_Business_Mix\" title=\"Key Products and Business Mix\">Key Products and Business Mix<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/hikal-vs-solara-active-pharma-sciences-comparison\/#Latest_Results_and_Financial_Data\" title=\"Latest Results and Financial Data\">Latest Results and Financial Data<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/hikal-vs-solara-active-pharma-sciences-comparison\/#Stock_Performance_and_Valuation\" title=\"Stock Performance and Valuation\">Stock Performance and Valuation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/hikal-vs-solara-active-pharma-sciences-comparison\/#Hikal_vs_Solara_Active_Pharma_Sciences_Quick_Comparison_Table\" title=\"Hikal vs Solara Active Pharma Sciences: Quick Comparison Table\">Hikal vs Solara Active Pharma Sciences: Quick Comparison Table<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/hikal-vs-solara-active-pharma-sciences-comparison\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/hikal-vs-solara-active-pharma-sciences-comparison\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/hikal-vs-solara-active-pharma-sciences-comparison\/#Is_Hikal_profitable\" title=\"Is Hikal profitable?\">Is Hikal profitable?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/hikal-vs-solara-active-pharma-sciences-comparison\/#Is_Solara_Active_Pharma_profitable\" title=\"Is Solara Active Pharma profitable?\">Is Solara Active Pharma profitable?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/hikal-vs-solara-active-pharma-sciences-comparison\/#What_does_Hikal_make\" title=\"What does Hikal make?\">What does Hikal make?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/hikal-vs-solara-active-pharma-sciences-comparison\/#What_does_Solara_Active_Pharma_make\" title=\"What does Solara Active Pharma make?\">What does Solara Active Pharma make?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/hikal-vs-solara-active-pharma-sciences-comparison\/#Are_Hikal_and_Solara_in_Nifty_50\" title=\"Are Hikal and Solara in Nifty 50?\">Are Hikal and Solara in Nifty 50?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/hikal-vs-solara-active-pharma-sciences-comparison\/#Which_is_larger_Hikal_or_Solara\" title=\"Which is larger, Hikal or Solara?\">Which is larger, Hikal or Solara?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/hikal-vs-solara-active-pharma-sciences-comparison\/#Should_I_invest_in_loss-making_pharma_API_companies\" title=\"Should I invest in loss-making pharma API companies?\">Should I invest in loss-making pharma API companies?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Reach_and_Market_Position\"><\/span><strong>Reach and Market Position<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>In this Hikal vs Solara Active Pharma Sciences comparison, Hikal manufactures pharma APIs and crop protection chemicals for global pharma and agrochemical companies. Market capitalisation is Rs 2,800 Cr.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=hikal-vs-solara\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<p>Solara Active Pharma Sciences manufactures complex APIs including ibuprofen, metformin and other regulated-market APIs. Market capitalisation is Rs 2,400 Cr.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Products_and_Business_Mix\"><\/span><strong>Key Products and Business Mix<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>For the Hikal vs Solara Active Pharma Sciences product breakdown, Hikal: Hikal earns from pharma APIs (antibiotics, antivirals) and agrochemical intermediates. EPS is -Rs 2.74 (loss-making). ROE is 3.03 percent (distorted by small losses). D\/E 0.57. Hikal is currently loss-making. Investors should verify current financials before any investment decision.<\/p>\n<p>Solara Active Pharma Sciences: Solara earns from complex pharma APIs for regulated markets. EPS is -Rs 0.34 (loss-making). ROE is -0.12 percent. D\/E 0.55. Solara Active Pharma Sciences is currently loss-making. Investors should verify current financials before any investment decision.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Latest_Results_and_Financial_Data\"><\/span><strong>Latest Results and Financial Data<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>On the Hikal vs Solara Active Pharma Sciences results front: Hikal has a market cap of Rs 2,800 Cr and is loss-making with EPS of -Rs 2.74. Hikal is 1.2 times larger than Solara on market cap. Both companies are in a challenging operational phase.<\/p>\n<p>Solara Active Pharma Sciences has a market cap of Rs 2,400 Cr and is loss-making with EPS of -Rs 0.34 and ROE of -0.12 percent. Both Hikal vs Solara are loss-making companies in the API manufacturing segment.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Compare Hikal and Solara Active Pharma Sciences Fundamentals on the Univest Screener<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Stock_Performance_and_Valuation\"><\/span><strong>Stock Performance and Valuation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Investors tracking the Hikal vs Solara Active Pharma Sciences comparison should verify current prices on NSE or BSE before trading. The Hikal vs Solara Active Pharma Sciences stock data below reflects the latest available figures from Groww and public company filings.<\/p>\n<p>Hikal vs Solara Active Pharma at current valuations: Both are loss-making. Hikal trades at approximately Rs 2,800 Cr market cap (loss-making). Solara trades at approximately Rs 2,400 Cr market cap (loss-making). The two API companies are similar in market cap size. NEITHER company is profitable at this time &#8211; investors should exercise extreme caution.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Hikal_vs_Solara_Active_Pharma_Sciences_Quick_Comparison_Table\"><\/span><strong>Hikal vs Solara Active Pharma Sciences: Quick Comparison Table<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The comparison table below summarises the key metrics side by side.<\/p>\n<table style=\"border-collapse: collapse; width: 100%;\">\n<tbody>\n<tr>\n<th style=\"border: 1px solid #ccc; padding: 8px;\">Parameter<\/th>\n<th style=\"border: 1px solid #ccc; padding: 8px;\"><a href=\"https:\/\/univest.in\/stocks\/hikal-ltd\">Hikal<\/a><\/th>\n<th style=\"border: 1px solid #ccc; padding: 8px;\"><a href=\"https:\/\/univest.in\/stocks\/solara-active-pharma-science-ltd\">Solara Active Pharma Sciences<\/a><\/th>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Sector<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Pharma APIs + crop protection chemicals (dual business)<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Complex pharma APIs for regulated markets (US, EU exports)<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Market Cap<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Rs 2,800 Cr<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Rs 2,400 Cr<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Profitability<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">LOSS-MAKING (EPS -2.74)<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">LOSS-MAKING (EPS -0.34)<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">ROE<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">3.03% (distorted)<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">\u22120.12% (losses)<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Debt to Equity<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">0.57<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">0.55<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Key Products<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Pharma APIs + herbicides, fungicides<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Ibuprofen, metformin, complex APIs<\/td>\n<\/tr>\n<tr>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Status<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Loss-making phase<\/td>\n<td style=\"border: 1px solid #ccc; padding: 8px;\">Loss-making phase<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Hikal vs Solara Active Pharma Sciences comparison above covers reach, products, results and valuation. Hikal vs Solara Active Pharma Sciences covers two Indian API manufacturers both currently in loss-making phases. Hikal has pharma API and crop protection chemical businesses. Solara has complex API manufacturing focused on regulated market exports. Hikal vs Solara investors must note that both companies are currently loss-making, and investment decisions should be made with detailed review of each company&#8217;s path to profitability, capex cycles and customer contracts. Consult a SEBI-registered advisor before investing in any loss-making company.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest\/id1543832872\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.android\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Hikal and Solara Active Pharma Sciences live price and get daily stock recommendations.<\/em><\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Is_Hikal_profitable\"><\/span><strong>Is Hikal profitable?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. Hikal is currently loss-making with EPS of -Rs 2.74. Investors should verify the latest quarterly results from exchange filings before any investment decision.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Solara_Active_Pharma_profitable\"><\/span><strong>Is Solara Active Pharma profitable?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. Solara Active Pharma Sciences is currently loss-making with EPS of -Rs 0.34 and ROE of -0.12 percent. Investors should review the latest financials from exchange filings carefully.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Hikal_make\"><\/span><strong>What does Hikal make?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Hikal manufactures pharma APIs for antibiotic and antiviral medicines and crop protection chemicals (herbicide, fungicide intermediates) for global agrochemical companies. It operates from Taloja and Jigani facilities.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Solara_Active_Pharma_make\"><\/span><strong>What does Solara Active Pharma make?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Solara Active Pharma Sciences manufactures complex APIs including ibuprofen, metformin and other active ingredients for regulated market pharma companies in the US and Europe.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Are_Hikal_and_Solara_in_Nifty_50\"><\/span><strong>Are Hikal and Solara in Nifty 50?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Neither is in Nifty 50. Both are tracked in smaller indices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_is_larger_Hikal_or_Solara\"><\/span><strong>Which is larger, Hikal or Solara?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Hikal at Rs 2,800 Cr is approximately 1.2 times larger than Solara Active Pharma Sciences at Rs 2,400 Cr.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_I_invest_in_loss-making_pharma_API_companies\"><\/span><strong>Should I invest in loss-making pharma API companies?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Loss-making companies carry significantly higher risk than profitable ones. Investors should carefully review the reasons for losses, the path to profitability, management guidance and financial health before investing. Consult a SEBI-registered investment advisor.<\/p>\n<div class=\"faq-schema\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Hikal vs Solara Active Pharma Sciences compared on API manufacturing, crop protection chemicals, ROE and valuation. Both currently loss-making companies.<\/p>\n","protected":false},"author":34,"featured_media":197671,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-197672","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["197671"],"_edit_lock":["1786509161:37"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["74"],"rank_math_title":["Hikal vs Solara Active Pharma: Which API Company Stock"],"rank_math_description":["Hikal vs Solara Active Pharma Sciences compared on API manufacturing, crop protection chemicals, ROE and valuation. Both currently loss-making companies."],"rank_math_focus_keyword":["Hikal vs Solara Active Pharma"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_last":["37"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["36100"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/hikal-vs-solara-active-pharma-sciences-comparison.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/197672","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=197672"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/197672\/revisions"}],"predecessor-version":[{"id":197886,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/197672\/revisions\/197886"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/197671"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=197672"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=197672"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=197672"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}